NuCana PLC (NCNA)
3.61
-0.01
(-0.28%)
USD |
NASDAQ |
May 31, 16:00
3.63
+0.02
(+0.55%)
After-Hours: 20:00
NuCana Accounts Payable (Quarterly): 7.277M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.277M |
December 31, 2023 | 4.299M |
September 30, 2023 | 6.313M |
June 30, 2023 | 5.902M |
March 31, 2023 | 7.048M |
December 31, 2022 | 5.813M |
September 30, 2022 | 6.269M |
June 30, 2022 | 2.597M |
March 31, 2022 | 3.545M |
December 31, 2021 | 2.468M |
September 30, 2021 | 5.224M |
June 30, 2021 | 2.349M |
March 31, 2021 | 4.868M |
December 31, 2020 | 3.076M |
Date | Value |
---|---|
September 30, 2020 | 5.390M |
June 30, 2020 | 2.373M |
March 31, 2020 | 3.038M |
December 31, 2019 | 3.162M |
September 30, 2019 | 2.649M |
June 30, 2019 | 2.903M |
March 31, 2019 | 2.945M |
December 31, 2018 | 3.115M |
September 30, 2018 | 3.306M |
June 30, 2018 | 2.776M |
March 31, 2018 | 1.257M |
December 31, 2017 | 1.514M |
June 30, 2017 | 0.7416M |
December 31, 2016 | 0.8944M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.349M
Minimum
Jun 2021
7.277M
Maximum
Mar 2024
4.328M
Average
3.922M
Median
Accounts Payable (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 6.587M |
Biodexa Pharmaceuticals Plc | 0.40M |
Verona Pharma PLC | 4.651M |
Autolus Therapeutics PLC | 1.399M |
Mereo BioPharma Group PLC | 2.455M |